biosimilars
Dr Reddy’s Q3 profit falls 14 pc to Rs 1,210 crore
Celltrion acquires US biopharma plant from Eli Lilly to counter tariff threats
S. Korea aims to double bio exports by 2030 to enter global top 5
Indian pharma market up by 7.9pc in July, cardiac & anti-diabetes therapies show strong volume
Dr. Reddy's Laboratories' net profit slumps 11 pc to Rs 14,09 crore sequentially in Q1